Nutrition and Healthy Aging xx (20xx) x-xx Abstract. Males and females typically have different lifespans and frequently differ in their responses to anti-aging interventions. These sex-specific responses are documented both in mice and Drosophila species, in addition to other organisms where interventions have been tested. While the prevalence of sex-specific responses to anti-aging interventions is now recognised, the underlying causes remain poorly understood. This review first summarises the main pathways and interventions that lead to sex-specific lifespan responses, including the growth-hormone/insulin-like growth factor 1 (GH-IGF1) axis, mechanistic target of rapamycin (mTOR) signalling, and nutritional and pharmacological interventions. After summarising current evidence, several different potential causes for sex-specific responses are discussed. These include sex-differences in xenobiotic metabolism, disease susceptibility, sex-specific hormone production and chromosomes, and the relative importance of different signalling pathways in the control of male and female life-history. Understanding why sex-differences in lifespan-extension occur should provide a greater understanding of the mechanisms that regulate the aging process in each sex, and will be crucial for understanding the full implications of these treatments if they are translated to humans. 8 (Saccharomyces cerevisiae) with rapamycin -which 34 inhibits target of rapamycin (mTOR) signalling -35 leads to lifespan extension [5], and on average the 36 change in median lifespan is similar in each of these 37 species [6]. In spite of this commonality, there are 38 factors within each species that influence the effec-39 tiveness of a particular intervention. Interventions 40 can have different levels of effectiveness in differ-41 ent strains [7], and treatment effects can interact with 42 environment conditions (e.g. temperature [8], diet 43
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Lifespan can now be extended through a vari- 
